Bliss GVS Pharma Ltd - BLISS GVS PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE416D01022
₹ 125.20 (-2.15%) icon22 Feb, 2024, 12:00:00 AM
Open
₹ 128.80
Prev. Close
₹ 127.95
Turnover(lac)
₹ 0.01
Day's High
₹ 128.80
Day's Low
₹ 123.00
52 Wk High
₹ 149.60
52 Wk Low
₹ 69.20
Book Value
₹ 95.44
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 1,310.73
P/E
19.21
EPS
6.52
Div. Yield
0.40

Bliss GVS Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/22/2024 12:00:00 AM

    ₹ 125.2 -2.75 -2.15
  • Open
  • ₹ 128.8
  • Prev. Close
  • ₹ 127.95
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 128.8
  • Day's Low
  • ₹ 123
  • 52 Week's High
  • ₹ 149.6
  • 52 Week's Low
  • ₹ 69.2
  • Book Value
  • ₹ 95.44
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 1,310.73
  • P/E
  • 19.21
  • EPS
  • 6.52
  • Divi. Yield
  • 0.4

Bliss GVS Pharma Ltd Corporate Actions

16 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Jan , 2024

12:00 AM

25 Oct , 2023

12:00 AM

25 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jul , 2023

12:00 AM

12 May , 2023

12:00 AM

AGM

Announcement date: 12 May , 2023

View Details

11 May , 2023

12:00 AM

Dividend

Dividend amount: 0.5
Announcement date: 11 May , 2023

View Details

04 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 May , 2023

12:00 AM

BookCloser

View Details

Bliss GVS Pharma Ltd News and Update

Image not found
  • 17 hours ago |
  • 12:06 AM

Think and Learn Pvt Ltd, the company that owns Byju's, is accused of breaking India's foreign exchange rules

Image not found
Image not found
  • IIFL News Service |
  • 19 February, 2024 |
  • 12:02 AM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Bliss GVS Pharma Ltd SHAREHOLDING SNAPSHOT
23 February , 2024 | 06:31 AM

PROMOTER - TOTAL34.97%

Indian: 34.97%

Foreign: 0%

NON-PROMOTER - TOTAL 65.03%

Institutions: 21.95%

Non-Institutions: 43.08%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Bliss GVS Pharma Ltd FINANCIALS

Bliss GVS Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Bliss GVS Pharma Ltd

  • Vibha G Sharma
  • Whole-time Director
  • Shruti Vishal Rao
  • Whole-time Director
  • Subramanian R Vaidya
  • Chairman & Independent Directo
  • Santosh Parab
  • Non-Exec. & Independent Dir.
  • Aditi Bhatt
  • Company Sec. & Compli. Officer
  • Shilpa Bhatia
  • Non-Exec. & Independent Dir.
  • Gagan Harsh Sharmma
  • Managing Director

Summary

Bliss GVS Pharma Ltd is an export-oriented pharmaceutical company. It is among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. Bliss GVS Pharma has presence in antimalarial, antifungal, antibacterial, anti-inflammatory and antibiotic therapeutic segments. It is a leading player in the antimalarial branded formulations segment. Bliss GVS Pharma is the only EU-GMP certified suppositories manufacturer in India.The company has a dedicated the R&D Centre for development of Suppositories, Semi Solids and Oral Solids with an experienced Team of over 50 Scientists for formulation development and analytical method development and certified by the Department of Scientific & Industrial Research (DSIR), Government of India.Incorporated in 1984 as a private limited company under the name Bliss Chemicals & Pharmaceuticals India Ltd, the company commenced its business in 1985. In 1994 the company introduced a new pharmaceutical product VAGID.During the financial year ended 31 March 2014, Bliss GVS Pharmas R&D center, received approval from Government of Indias Department for Scientific & Industrial Research (DSIR).During the year under review, the company invested in 51% share capital of Lifeon Labs Pvt Ltd. During the year under review, Bliss GVS Pharma faced challenges in Ghana, where delays in registration resulted in adverse regulatory action. However, the company took quick, corrective measures to resolve these issues.... Read More


Reports by Bliss GVS Pharma Ltd


Reports by Bliss GVS Pharma Ltd

Company FAQ

No Record Found